Our study presents preliminary but promising results suggesting that suprazygomatic maxillary nerve block [SMNB] may reduce perioperative opioid consumption in pediatric primary clefts particularly ...
December 12, 2025 — For infants undergoing cleft palate surgery, local anesthetic injection targeting the maxillary nerve of the face may reduce or eliminate the need for opioid medications to control ...
A nerve block administered to a nerve that provides sensation to the palate, upper jaw and upper lip halts pain during the surgery and significantly reduces it afterward, researchers recently reported ...
LIVINGSTON, NJ--(Marketwired - August 18, 2016) - Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of ...
7 of 10 babies needed no opioids at all to manage post-surgery pain FRIDAY, Dec. 19, 2025 (HealthDay News) — Using a nerve blocker before surgery to correct cleft palate can reduce or eliminate the ...
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it has ...
7 of 10 babies needed no opioids at all to manage post-surgery pain Originally published on healthday.com, part of the BLOX Digital Content Exchange.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results